Literature DB >> 10428248

Social phobia in the primary care medical setting.

M B Stein1, J R McQuaid, C Laffaye, M E McCahill.   

Abstract

BACKGROUND: Social phobia (social anxiety disorder) is a common disorder that is receiving more attention as new treatments become available. Little is known about social phobia as it appears in the primary care setting. The purpose of our study was to determine the prevalence of social phobia in a primary care clinic, the rates of comorbidity with other anxiety and mood disorders, the extent of disability, and patterns of healthcare utilization.
METHODS: A total of 511 English-speaking adults presenting for routine medical care participated in a 2-stage screening consisting of the administration of a self-report measure for social phobia followed by a structured diagnostic interview. We determined current (1-month) prevalence of social phobia, current comorbid disorders, and we ascertained use of health care in the previous 6 months. We also administered brief functional impairment and disability indices.
RESULTS: A lower-bound estimate of 7.0% of primary care attendees suffered from social phobia as defined in the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition. Comorbidity with major depression (58.3% of cases of social phobia) was extensive, somewhat less so with panic disorder (27.8%) and generalized anxiety disorder (30.6%). Social phobics reported significantly more impairment in all functional domains than primary care patients without mental disorders; this was most pronounced in patients with the generalized subtype of social phobia. Social phobics made greater use of health care resources than patients who were not mentally ill, yet few (<20%) were receiving appropriate psychotropic medications.
CONCLUSIONS: Patients with social phobia frequently present to primary care medical settings, and manifest impairment in multiple functional domains. But, on the basis of the low rate of psychotropic prescription, it seems that social phobia is either undiagnosed or felt by physicians to be unlikely to benefit from such treatments. Social phobia is highly comorbid with major depression and with other anxiety disorders in the primary care setting. Attention by family physicians to the presence of depression or panic attacks should signal the need to query patients about possible social phobia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428248

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  15 in total

Review 1.  Unmasking social anxiety disorder.

Authors:  M B Stein; J M Gorman
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 2.  Social anxiety disorder: recent findings in the areas of epidemiology, etiology, and treatment.

Authors:  C Blanco; K Nissenson; M R Liebowitz
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

3.  Socially anxious primary care patients' attitudes toward cognitive bias modification (CBM): a qualitative study.

Authors:  Courtney Beard; Risa B Weisberg; Jennifer Primack
Journal:  Behav Cogn Psychother       Date:  2011-11-30

4.  Characteristics and predictors of social phobia course in a longitudinal study of primary-care patients.

Authors:  Courtney Beard; Ethan Moitra; Risa B Weisberg; Martin B Keller
Journal:  Depress Anxiety       Date:  2010-09       Impact factor: 6.505

5.  Cognitive therapy compared with CBT for social anxiety disorder in adolescents: a feasibility study.

Authors:  Cathy Creswell; Eleanor Leigh; Michael Larkin; Gareth Stephens; Mara Violato; Emma Brooks; Samantha Pearcey; Lucy Taylor; Paul Stallard; Polly Waite; Shirley Reynolds; Gordon Taylor; Emma Warnock-Parkes; David M Clark
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

6.  A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.

Authors:  Peter P Roy-Byrne; Michelle G Craske; Murray B Stein; Greer Sullivan; Alexander Bystritsky; Wayne Katon; Daniela Golinelli; Cathy D Sherbourne
Journal:  Arch Gen Psychiatry       Date:  2005-03

7.  Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

Authors:  Murray B Stein; Mark H Pollack; Alexander Bystritsky; Jeffrey E Kelsey; Richard M Mangano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

8.  Mental disorders in primary care in Israel: prevalence and risk factors.

Authors:  Neil Laufer; Nelly Zilber; Pablo Jecsmien; Binyamin Maoz; Daniel Grupper; Haggai Hermesh; Royi Gilad; Abraham Weizman; Hanan Munitz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-01-04       Impact factor: 4.328

9.  Social Anxiety Disorder: More Than Just a Little Shyness.

Authors:  James W. Jefferson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-02

10.  Employment barriers, skills, and aspirations among unemployed job seekers with and without social anxiety disorder.

Authors:  Joseph A Himle; Addie Weaver; Deborah Bybee; Lisa O'Donnell; Sarah Vlnka; Wayne Laviolette; Edward Steinberger; Zipora Golenberg; Debra Siegel Levine
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.